4319-68-0 Usage
Uses
Used in Pharmaceutical Industry:
4'-Deoxyphlorizin is used as an inhibitor of the glucose transport system for its potential role in managing and treating diabetes. By inhibiting the glucose transport system, it may help regulate blood sugar levels and provide a therapeutic approach to diabetes management.
Used in Research and Development:
In the field of research and development, 4'-Deoxyphlorizin serves as a valuable compound for studying the mechanisms of glucose transport and its regulation. This knowledge can be applied to develop new drugs and therapies for diabetes and other related conditions.
Used in Drug Design and Development:
4'-Deoxyphlorizin's ability to inhibit the glucose transport system makes it a promising candidate for drug design and development. Researchers can use 4'-Deoxyphlorizin as a starting point to create new drugs that target glucose transport, potentially leading to more effective treatments for diabetes and other glucose-related disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 4319-68-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 4319-68:
(6*4)+(5*3)+(4*1)+(3*9)+(2*6)+(1*8)=90
90 % 10 = 0
So 4319-68-0 is a valid CAS Registry Number.
InChI:InChI=1/C21H24O9/c22-10-16-18(26)19(27)20(28)21(30-16)29-15-3-1-2-13(24)17(15)14(25)9-6-11-4-7-12(23)8-5-11/h1-5,7-8,16,18-24,26-28H,6,9-10H2
4319-68-0Relevant academic research and scientific papers
Na+-glucose cotransporter inhibitors as antidiabetics. I. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives based on a new concept
Tsujihara, Kenji,Hongu, Mitsuya,Saito, Kunio,Inamasu, Masanori,Arakawa, Kenji,Oku, Akira,Matsumoto, Mamoru
, p. 1174 - 1180 (2007/10/03)
Based on our new concept that inhibitors of the Na+-glucose cotransporter (SGLT) would be useful as antidiabetics, 4'-dehydroxyphlorizin derivatives 1a-f were designed, synthesized, and examined for various pharmacological properties related to